LIT-001 TFA
LIT-001 is the First Nonpeptide Oxytocin Receptor Agonist that Improves Social Interaction in a Mouse Model of Autism.
| Supplier | Ace Therapeutics |
|---|---|
| Product # | SMD453 |
| CAS # | 2245072-21-1 (TFA) |
| Pricing | Customizable size, Inquiry |
| Synonym | LIT-001; LIT 001; LIT001; LIT-001 TFA; LIT-001; LIT001; LIT 001; |
| Product Category | Lab-use Small Molecule Drugs |
| Chemical Formula | C30H34F3N7O4S |
| Molecular Weight | 645.7022 |
| Elemental Analysis | C, 55.80; H, 5.31; F, 8.83; N, 15.18; O, 9.91; S, 4.97 |
| IUPAC/Chemical Name | (S)-2-(Dimethylcarbamothioyl)-N-(2-methyl-4-(1-methyl-1,4,5,10-tetrahydrobenzo[b]pyrazolo[3,4-e][1,4]diazepine-5-carbonyl)benzyl)pyrrolidine-1-carboxamide, Trifluoroacetate |
| InChi Key | BZHSRXWFCSEPQQ-JIDHJSLPSA-N |
| InChi Code | InChI=1S/C28H33N7O2S.C2HF3O2/c1-18-14-19(11-12-20(18)15-29-28(37)34-13-7-10-24(34)27(38)32(2)3)26(36)35-17-21-16-30-33(4)25(21)31-22-8-5-6-9-23(22)35;3-2(4,5)1(6)7/h5-6,8-9,11-12,14,16,24,31H,7,10,13,15,17H2,1-4H3,(H,29,37);(H,6,7)/t24-;/m0./s1 |
| SMILES Code | O=C(N1[C@H](C(N(C)C)=S)CCC1)NCC2=CC=C(C(N3C4=CC=CC=C4NC(N(C)N=C5)=C5C3)=O)C=C2C.O=C(O)C(F)(F)F |
| Appearance | Solid powder |
| Purity | >98% (or refer to the Certificate of Analysis) |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
| Storage Condition | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO |
| Shelf Life | >3 years if stored properly |
| Drug Formulation | This drug may be formulated in DMSO |
| Stock Solution Storage | 0 - 4℃ for short term (days to weeks), or -20℃ for long term (months). |
| HS Tariff Code | 2934.99.9001 |
| Availability | 2 Weeks |